These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18565491)

  • 1. [Molecular effects of new calcium antagonists: is the principle of parcimony out of place?].
    Richard S; Virsolvy A; Fort A
    Ann Cardiol Angeiol (Paris); 2008 Jun; 57(3):166-73. PubMed ID: 18565491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage.
    Ishiguro M; Wellman TL; Honda A; Russell SR; Tranmer BI; Wellman GC
    Circ Res; 2005 Mar; 96(4):419-26. PubMed ID: 15692089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2.
    Moosmang S; Haider N; Brüderl B; Welling A; Hofmann F
    Circ Res; 2006 Jan; 98(1):105-10. PubMed ID: 16306443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal protective action of T-, L-, and N-type Ca channel blockers].
    Hayashi K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():654-61. PubMed ID: 15171451
    [No Abstract]   [Full Text] [Related]  

  • 8. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.
    Major TC; Dhamija S; Black N; Liachenko S; Morenko B; Sobocinski G; Okerberg C; Tinholt P; Madore S; Kowala MC
    J Pharmacol Exp Ther; 2008 Jun; 325(3):723-31. PubMed ID: 18326812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of L- and T-type calcium channels in local and remote calcium responses in rat mesenteric terminal arterioles.
    Braunstein TH; Inoue R; Cribbs L; Oike M; Ito Y; Holstein-Rathlou NH; Jensen LJ
    J Vasc Res; 2009; 46(2):138-51. PubMed ID: 18765948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
    Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
    Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of voltage-gated L-type calcium channels by labedipinedilol-A involves protein kinase C in rat cerebrovascular smooth muscle cells.
    Wu BN; Chen ML; Dai ZK; Lin YL; Yeh JL; Wu JR; Chen IJ
    Vascul Pharmacol; 2009; 51(2-3):65-71. PubMed ID: 19298869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.
    Hansen PB
    Acta Physiol (Oxf); 2013 Apr; 207(4):690-9. PubMed ID: 23351056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of new dihydropyridine calcium channel blockers in the treatment of hypertension].
    Coca A
    An Med Interna; 2003 Jun; 20(6):279-81. PubMed ID: 12848596
    [No Abstract]   [Full Text] [Related]  

  • 14. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
    Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
    Furukawa T; Nukada T; Namiki Y; Miyashita Y; Hatsuno K; Ueno Y; Yamakawa T; Isshiki T
    Eur J Pharmacol; 2009 Jun; 613(1-3):100-7. PubMed ID: 19401195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of (S)-amlodipine and (R)-amlodipine on L-type calcium channel current of rat ventricular myocytes and cytosolic calcium of aortic smooth muscle cells.
    Wang RX; Jiang WP; Li XR; Lai LH
    Pharmazie; 2008 Jun; 63(6):470-4. PubMed ID: 18604992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New calcium channel blockers for the treatment of hypertension].
    Tamargo J
    Hipertens Riesgo Vasc; 2017; 34 Suppl 2():5-8. PubMed ID: 29908667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-channel-selective calcium channel blockade: a promising therapeutic possibility, only preliminarily tested so far: a review of published data. T-Channel Calcium Channel Blocker Study Group.
    Van der Vring JA; Cleophas TJ; Van der Wall EE; Niemeyer MG
    Am J Ther; 1999 Jul; 6(4):229-33. PubMed ID: 11329102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen sulfide evokes neurite outgrowth and expression of high-voltage-activated Ca2+ currents in NG108-15 cells: involvement of T-type Ca2+ channels.
    Nagasawa K; Tarui T; Yoshida S; Sekiguchi F; Matsunami M; Ohi A; Fukami K; Ichida S; Nishikawa H; Kawabata A
    J Neurochem; 2009 Feb; 108(3):676-84. PubMed ID: 19054275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hypertension and calcium-channel blockers.
    Kanneganti M; Halpern NA
    New Horiz; 1996 Feb; 4(1):19-25. PubMed ID: 8689271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.